person-centred interventions: The clinic treatment is a person-centred interventions that support smoking cessation, health promotion, rehabilitation participation, and long-term recovery among individuals with mental disorders.
Study summary
Mental disorders are often accompanied by health-risk behaviours, psychiatric comorbidity, and reduced functioning. TORCH investigates transdiagnostic mechanisms underlying multiple health behaviour change in adult psychiatric patients, with a focus on nicotine dependence and smoking. Based on the Compensatory Carry-Over Action Model (CCAM), the project examines self-efficacy, motivation, stress regulation, coping, and social support in relation to psychiatric symptoms and rehabilitation outcomes. Using a multimethod, naturalistic observational design, quantitative and qualitative data will be collected in inpatient and day-care psychiatry to identify mechanisms that support health behaviour change and rehabilitation.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria
Participants must:
be affected by nicotine dependence
Be 18 years of age or older.
Be currently receiving inpatient or day-care psychiatric treatment at the Department of Psychiatry and Psychotherapy, Kreiskrankenhaus Prignitz.
Be capable of understanding study information and providing informed consent.
Possess sufficient German language proficiency to complete assessments and interviews.
Agree to participate voluntarily.
Exclusion Criteria
Participants will be excluded if they:
Experience acute psychiatric symptoms that substantially impair informed consent capacity.
Are acutely intoxicated or experiencing severe withdrawal symptoms at the time of recruitment.
Demonstrate insufficient decisional capacity according to clinical assessment.
Do not have adequate German language proficiency.
Have any condition judged by the treating clinical team to render participation inappropriate or excessively burdensome.
Primary outcome measure(s)
BIS-15 — Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge). Barratt Impulsiveness Scale (BIS) is measuring behavioral inhibition (On a scale of 1 to 4: 1-rarely/never, 2-occasionally, 3-often, 4-almost always/always).
FEVER — Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge). Fragebogen zur Erfassung der Veränderungsbereitschaft (FEVER) is measuring readiness to hange / change motivation. On a scale of 1 to 5: 1-not at all applicable, 2-rather not applicable, 3-don't know/undecided, 4-rather applicable, 5-fully applicable.
F-SozU K-14 — Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge). F-SozU K-14 is a Social Support Questionnaire. On a scale of 1 to 5: 1-not applicable, 2-rather not applicable, 3-partly applicable, 4-applicable, 5-exactly applicable.
Fagerström Test — Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge). Fagerström Test is measuring smoking behavior. Higher values mean higher consumption.
Trial sites (1)
Facility
City
Region
Status
Kreiskrankenhaus Prignitz gemeinnützige GmbH
Perleberg
Germany
More Jacobs University Bremen gGmbH trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
